TrademarkDir
TRYNGOLZA
LIVE

Serial Number

98913093

Owner

Ionis Pharmaceuticals, Inc.

Attorney

Brian Focarino

First Use Date

Dec 30, 2024

Filing Date

Dec 19, 2024

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

TRYNGOLZA Trademark

Serial Number: 98913093 • Registration: 8298354

TRYNGOLZA is a trademark filed by Ionis Pharmaceuticals, Inc. on December 19, 2024. The trademark is classified under Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Ionis Pharmaceuticals, Inc. (10 trademarks)

2855 Gazelle Court
Carlsbad, CA 92010

Entity Type: 03

Trademark Details

Filing Date

December 19, 2024

Registration Date

June 9, 2026

First Use Anywhere

December 30, 2024

First Use in Commerce

December 30, 2024

Published for Opposition

June 3, 2025

Goods & Services

Medical services; medical information services; providing a website featuring medical and healthcare information for healthcare professionals, caregivers, patients, and providers in the field of genetic diseases and disorders; medical consulting services in the field of genetic diseases and disorders; healthcare services, namely, providing an online database of medical and healthcare information in the field of genetic diseases and disorders, and collecting data and information on genetic diseases and disorders for treatment and diagnostic purposes; providing medical and healthcare information concerning the screening, diagnosis, and treatment of genetic diseases and disorders; providing a website featuring medical and healthcare information for healthcare professionals, caregivers, patients, and providers in the field of cardiovascular, metabolic, neurological and inflammatory diseases and disorders; medical consulting services in the field of cardiovascular, metabolic, neurological and inflammatory diseases and disorders; healthcare services, namely, providing an online database of medical and healthcare information in the field of cardiovascular, metabolic, neurological and inflammatory diseases and disorders, and collecting data and information on cardiovascular, metabolic, neurological and inflammatory diseases and disorders for treatment and diagnostic purposes; providing medical and healthcare information concerning the screening, diagnosis, and treatment of cardiovascular, metabolic, neurological and inflammatory diseases and disorders

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 9, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 9, 2026 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
May 21, 2026 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
May 21, 2026 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Apr 8, 2026 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 6, 2026 AITU
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 3, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 3, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 3, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 3, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 3, 2026 COAR
USE AMENDMENT FILED
Oct 10, 2025 IUAF
TEAS STATEMENT OF USE RECEIVED
Oct 10, 2025 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 7, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 3, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jun 3, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 28, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 1, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 25, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 25, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 25, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 24, 2025 GNRN
NON-FINAL ACTION E-MAILED
Apr 24, 2025 GNRT
NON-FINAL ACTION WRITTEN
Apr 24, 2025 CNRT
ASSIGNED TO EXAMINER
Apr 23, 2025 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Apr 22, 2025 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 22, 2025 NWOS
NEW APPLICATION ENTERED
Dec 19, 2024 NWAP

Related Trademarks

More from this Owner

EXPAND WHAT'S POSSIBLE IN TRIGLYCERIDE REDUCTION

EXPAND WHAT'S POSSIBLE IN TRIGLYCERIDE REDUCTION

LET'S TALK TRIGLYCERIDES

LET'S TALK TRIGLYCERIDES

KNOW YOUR TRIGLYCERIDES

KNOW YOUR TRIGLYCERIDES

KNOW YOUR TRIGLYCERIDES

KNOW YOUR TRIGLYCERIDES

KNOW YOUR TRIGLYCERIDES

KNOW YOUR TRIGLYCERIDES

KNOW YOUR TRIGLYCERIDES

KNOW YOUR TRIGLYCERIDES